22 February 2002 :
An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting.
Med Sci Monit 2002; 8(2): PI9-15 :: ID: 420923
HTML version available soon